Form 4 for ARVN ARVINAS, INC.
Accepted 2022-01-04 00:00:00 ET · period of report 2021-12-30 · accession 0001209191-22-001202 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-04 | 2021-12-30 | ARVN | Peck Ronald | Chief Medical Off | S - Sale+OE | $80.61 | -20.0K | 5,402 | -79% | -$1.61M |
| DM | 2022-01-04 | 2021-12-30 | ARVN | Peck Ronald | Chief Medical Off | M - OptEx | $41.53 | +20.0K | 19.8K | New | +$830.6K |
| DM | 2022-01-04 | 2021-12-30 | ARVN | Peck Ronald | Chief Medical Off | M - OptEx | $0.00 | -20.0K | 40.6K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-30 | S | D | 11,371 | $80.35 | 14,031 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.76 to $80.755, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range set forth in this footnote. |
| 2 | Common | Common Stock | 2021-12-30 | M | A | 5,625 | $26.58 | 25,402 | D | — | — | |
| 3 | Common | Common Stock | 2021-12-30 | M | A | 14,375 | $47.38 | 19,777 | D | — | — | |
| 4 | Common | Common Stock | 2021-12-30 | S | D | 8,629 | $80.96 | 5,402 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.76 to $81.515, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range set forth in this footnote. |
| 5 | Derivative | Stock Option (right to buy) | 2021-12-30 | M | D | 5,625 | $0.00 | 46,559 | D | $26.58 · — to 2029-07-28 | 5,625 Common Stock | (F6) This option award was granted on July 29, 2019. 1/4 of the shares underlying the award vested on July 29, 2020, with the remainder of the shares vesting in equal monthly installments following July 29, 2020 through July 29, 2023. |
| 6 | Derivative | Stock Option (right to buy) | 2021-12-30 | M | D | 14,375 | $0.00 | 40,625 | D | $47.38 · — to 2030-02-26 | 14,375 Common Stock | (F5) This option award was granted on February 27, 2020. 1/4 of the shares underlying the award vested on February 27, 2021, with the remainder of the shares vesting in equal monthly installments following February 27, 2021 through February 27, 2024. |